Other Species / Isoforms
  GATA3 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S110-p
LGSHHTAsPWNLsPF
0 6
GATA3 (human) LGSHHTAsPWNLsPF S110-p
GATA3 iso2 (human) LGSHHTASPWNLSPF S110
GATA3 (mouse) LSSHHTASPWNLsPF S109
GATA3 (rat) LSSHHTASPWNLSPF S110
S115-p
TAsPWNLsPFSKTSI
Upstream
0 24
Treatment
  • ischemia
GATA3 (human) TAsPWNLsPFSKTSI S115-p
GATA3 iso2 (human) TASPWNLSPFSKTSI S115
GATA3 (mouse) TASPWNLsPFSKTSI S114-p
GATA3 (rat) TASPWNLSPFSKTSI S115
T156-p
HLFTFPPtPPKDVsP
Upstream
Downstream
1 0
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Kinase, in vitro:
  • CDK2 (human)
Putative in vivo kinases:
  • CDK2 (human)
GATA3 (human) HLFTFPPtPPKDVsP T156-p
GATA3 iso2 (human) HLFTFPPTPPKDVSP T156
GATA3 (mouse) HLFTFPPtPPKDVsP T155-p
GATA3 (rat) HLFTFPPTPPKDVsP T156
S162-p
PtPPKDVsPDPsLST
1 11
GATA3 (human) PtPPKDVsPDPsLST S162-p
GATA3 iso2 (human) PTPPKDVSPDPSLST S162
GATA3 (mouse) PtPPKDVsPDPSLST S161-p
GATA3 (rat) PTPPKDVsPDPSLST S162-p
S166-p
KDVsPDPsLSTPGsA
0 1
GATA3 (human) KDVsPDPsLSTPGsA S166-p
GATA3 iso2 (human) KDVSPDPSLSTPGSA S166
GATA3 (mouse) KDVsPDPSLSTPGsA S165
GATA3 (rat) KDVsPDPSLSTPGSA S166
S172-p
PsLSTPGsAGSARQD
0 2
GATA3 (human) PsLSTPGsAGSARQD S172-p
GATA3 iso2 (human) PSLSTPGSAGSARQD S172
GATA3 (mouse) PSLSTPGsAGSARQD S171-p
GATA3 (rat) PSLSTPGSAGSARQD S172
Y186-p
DEKECLKyQVPLPDS
0 1
GATA3 (human) DEKECLKyQVPLPDS Y186-p
GATA3 iso2 (human) DEKECLKYQVPLPDS Y186
GATA3 (mouse) DEKECLKYQVQLPDS Y185
GATA3 (rat) DEKECLKYQVQLPDS Y186
K195-ub
VPLPDSMkLESSHSR
0 1
GATA3 (human) VPLPDSMkLESSHSR K195-ub
GATA3 iso2 (human) VPLPDSMKLESSHSR K195
GATA3 (mouse) VQLPDSMKLETSHSR K194
GATA3 (rat) VQLPDSMKLETSHSR K195
S258
SRPKARSSTGrECVN
0 2
GATA3 (human) SRPKARSSTGrECVN S258
GATA3 iso2 (human) SRPKARSsTEGRECV S258-p
GATA3 (mouse) SRPKARSsTEGRECV S257-p
GATA3 (rat) SRPKARSSTEGRECV S258
R261-m2
KARSSTGrECVNCGA
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, inhibited
GATA3 (human) KARSSTGrECVNCGA R261-m2
GATA3 iso2 (human) ARSsTEGRECVNCGA R262
GATA3 (mouse) ARSsTEGRECVNCGA R261
GATA3 (rat) ARSSTEGRECVNCGA R262
T271-p
VNCGATStPLWRRDG
0 1
GATA3 (human) VNCGATStPLWRRDG T271-p
GATA3 iso2 (human) VNCGATSTPLWRRDG T272
GATA3 (mouse) VNCGATSTPLWRRDG T271
GATA3 (rat) VNCGATSTPLWRRDG T272
Y282-p
RRDGTGHyLCNACGL
0 2
GATA3 (human) RRDGTGHyLCNACGL Y282-p
GATA3 iso2 (human) RRDGTGHYLCNACGL Y283
GATA3 (mouse) RRDGTGHYLCNACGL Y282
GATA3 (rat) RRDGTGHYLCNACGL Y283
Y290-p
LCNACGLyHkMNGQN
0 3
GATA3 (human) LCNACGLyHkMNGQN Y290-p
GATA3 iso2 (human) LCNACGLYHKMNGQN Y291
GATA3 (mouse) LCNACGLYHKMNGQN Y290
GATA3 (rat) LCNACGLYHKMNGQN Y291
K292-ac
NACGLyHkMNGQNRP
1 0
GATA3 (human) NACGLyHkMNGQNRP K292-ac
GATA3 iso2 (human) NACGLYHKMNGQNRP K293
GATA3 (mouse) NACGLYHKMNGQNRP K292
GATA3 (rat) NACGLYHKMNGQNRP K293
K304-ac
NRPLIKPkRRLsAAR
1 0
GATA3 (human) NRPLIKPkRRLsAAR K304-ac
GATA3 iso2 (human) NRPLIKPKRRLSAAR K305
GATA3 (mouse) NRPLIKPKRRLsAAR K304
GATA3 (rat) NRPLIKPKRRLSAAR K305
S308-p
IKPkRRLsAARRAGT
Upstream
Downstream
4 0
Effects on Modified Protein
  • activity, induced
  • protein degradation
Effects on Biological Processes:
  • cell growth, induced
  • transcription, induced
Putative in vivo kinases:
  • PKACA (human)
Treatment
  • bortezomib
  • H-89
  • medroxyprogesterone
  • mPKI
GATA3 (human) IKPkRRLsAARRAGT S308-p
GATA3 iso2 (human) IKPKRRLSAARRAGT S309
GATA3 (mouse) IKPKRRLsAARRAGT S308-p
GATA3 (rat) IKPKRRLSAARRAGT S309
K346-ac
NACGLYYkLHNINRP
1 0
GATA3 (human) NACGLYYkLHNINRP K346-ac
GATA3 iso2 (human) NACGLYYKLHNINRP K347
GATA3 (mouse) NACGLYYKLHNINRP K346
GATA3 (rat) NACGLYYKLHNINRP K347
K358
NRPLTMKKEGIQTRN
0 1
GATA3 (human) NRPLTMKKEGIQTRN K358
GATA3 iso2 (human) NRPLTMKKEGIQTRN K359
GATA3 (mouse) NRPLTMKkEGIQTRN K358-ac
GATA3 (rat) NRPLTMKKEGIQTRN K359
S369-p
QTRNRKMsSkSkkCk
0 28
GATA3 (human) QTRNRKMsSkSkkCk S369-p
GATA3 iso2 (human) QTRNRKMSSKSKKCK S370
GATA3 (mouse) QTRNRKMSSKSKKCK S369
GATA3 (rat) QTRNRKMSSKSKKCK S370
K371-ac
RNRKMsSkSkkCkkV
0 1
GATA3 (human) RNRKMsSkSkkCkkV K371-ac
GATA3 iso2 (human) RNRKMSSKSKKCKKV K372
GATA3 (mouse) RNRKMSSKSKKCKKV K371
GATA3 (rat) RNRKMSSKSKKCKKV K372
K373-ac
RKMsSkSkkCkkVHD
0 1
GATA3 (human) RKMsSkSkkCkkVHD K373-ac
GATA3 iso2 (human) RKMSSKSKKCKKVHD K374
GATA3 (mouse) RKMSSKSKKCKKVHD K373
GATA3 (rat) RKMSSKSKKCKKVHD K374
K374-ac
KMsSkSkkCkkVHDs
0 1
GATA3 (human) KMsSkSkkCkkVHDs K374-ac
GATA3 iso2 (human) KMSSKSKKCKKVHDS K375
GATA3 (mouse) KMSSKSKKCKKVHDA K374
GATA3 (rat) KMSSKSKKCKKVHDA K375
K376-ac
sSkSkkCkkVHDsLE
0 1
GATA3 (human) sSkSkkCkkVHDsLE K376-ac
GATA3 iso2 (human) SSKSKKCKKVHDSLE K377
GATA3 (mouse) SSKSKKCKKVHDALE K376
GATA3 (rat) SSKSKKCKKVHDALE K377
K377-ub
SkSkkCkkVHDsLED
0 1
GATA3 (human) SkSkkCkkVHDsLED K377-ub
GATA3 iso2 (human) SKSKKCKKVHDSLED K378
GATA3 (mouse) SKSKKCKKVHDALED K377
GATA3 (rat) SKSKKCKKVHDALED K378
S381-p
kCkkVHDsLEDFPKN
Upstream
0 4
Treatment
  • ischemia
GATA3 (human) kCkkVHDsLEDFPKN S381-p
GATA3 iso2 (human) KCKKVHDSLEDFPKN S382
GATA3 (mouse) KCKKVHDALEDFPKS A381
GATA3 (rat) KCKKVHDALEDFPKS A382